Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$304.11 - $351.99 $642,888 - $744,106
2,114 New
2,114 $731,000
Q3 2023

Oct 23, 2023

SELL
$350.25 - $422.63 $16,461 - $19,863
-47 Reduced 6.52%
674 $242,000
Q2 2023

Aug 10, 2023

BUY
$359.49 - $486.4 $13,660 - $18,483
38 Added 5.56%
721 $273,000
Q1 2023

May 11, 2023

SELL
$418.69 - $503.0 $22,609 - $27,162
-54 Reduced 7.33%
683 $327,000
Q4 2022

Feb 07, 2023

SELL
$351.71 - $456.01 $89,686 - $116,282
-255 Reduced 25.71%
737 $309,000
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $8,664 - $11,828
21 Added 2.16%
992 $413,000
Q2 2022

Jul 19, 2022

BUY
$463.67 - $597.16 $127,509 - $164,219
275 Added 39.51%
971 $480,000
Q1 2022

May 04, 2022

BUY
$524.57 - $735.42 $17,310 - $24,268
33 Added 4.98%
696 $392,000
Q4 2021

Jan 31, 2022

SELL
$708.84 - $794.68 $148,147 - $166,088
-209 Reduced 23.97%
663 $500,000
Q3 2021

Oct 29, 2021

SELL
$657.71 - $825.77 $37,489 - $47,068
-57 Reduced 6.14%
872 $650,000
Q2 2021

Aug 11, 2021

BUY
$576.64 - $649.04 $65,160 - $73,341
113 Added 13.85%
929 $598,000
Q1 2021

May 04, 2021

SELL
$547.01 - $662.35 $261,470 - $316,603
-478 Reduced 36.94%
816 $466,000
Q4 2020

Feb 11, 2021

SELL
$510.68 - $643.45 $279,852 - $352,610
-548 Reduced 29.75%
1,294 $754,000
Q3 2020

Nov 05, 2020

BUY
$454.43 - $535.6 $483,967 - $570,414
1,065 Added 137.07%
1,842 $949,000
Q2 2020

Aug 12, 2020

BUY
$334.87 - $493.06 $14,734 - $21,694
44 Added 6.0%
777 $350,000
Q1 2020

May 11, 2020

SELL
$320.01 - $409.07 $12,480 - $15,953
-39 Reduced 5.05%
733 $256,000
Q4 2019

Feb 05, 2020

SELL
$319.73 - $374.2 $1,278 - $1,496
-4 Reduced 0.52%
772 $285,000
Q3 2019

Oct 30, 2019

BUY
$304.55 - $345.24 $236,330 - $267,906
776 New
776 $258,000
Q4 2018

Feb 11, 2019

SELL
$220.1 - $309.0 $155,830 - $218,772
-708 Closed
0 $0
Q3 2018

Nov 06, 2018

SELL
$289.28 - $326.15 $1,446 - $1,630
-5 Reduced 0.7%
708 $221,000
Q2 2018

Jul 31, 2018

BUY
$244.1 - $303.88 $174,043 - $216,666
713 New
713 $206,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.